ASSOCIATION BETWEEN THE ABO BLOOD GROUP AND COVID-19 SUSCEPTIBILITY IN INDIAN POPULATION: A RETROSPECTIVE ANALYSIS

Main Article Content

Dr. Sangita Kadu
Dr. Shreyak Kadu
Dr. Aakriti Aggrawal
Dr Prafulla Kadu
Dr. Priya Kadu

Keywords

Covid-19, susceptibility, ABO blood group

Abstract

Background: COVID-19 was declared a global crisis by the WHO.  Recent studies have reported variable susceptibility to COVID-19 infections based on blood group. There is a paucity of data on the Indian population regarding the relationship between COVID-19 positivity and blood grouping. The objective was to determine the association between blood groups and the prevalence of COVID-19 positivity.


Methodology: Data was reviewed on all patients who presented to Gurukrupa Hospital, Amravati from March 2020 to June 2021. A total of 772 subjects, between the age groups of 18-91 years were included in the study. COVID-19 positivity, ABO, and Rh typing were determined based on their health records in the institute. The association between COVID-19 positivity and blood group was studied using Chi-square test. The association between COVID-19 positivity and comorbidities such as diabetes and hypertension was evaluated using Chi-square test.


Result: In total, 772 patients were included, with the majority being male patients at 61.40%.Among, 772 patients, 150 patients (19.43 %) had diabetes mellitus, as well as 313 patients (40.54%) were found to have hypertension. Based on the analysis, A+, B+, and O+ blood groups showed a higher number of COVID-19 positive results. The incidence of COVID-19 positivity among individuals with hypertension was found to be 48.36%, whereas among those with Diabetes Mellitus, it was 22.64%.


Conclusion: The association between blood groups and COVID-19 infection is complex with multiple factors such as comorbidities, age, sex, and the distribution of blood groups in the population. The prevalence of COVID-19 is greater in hypertensive subjects.

Abstract 42 | pdf Downloads 20

References

1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30. PMID: 32007143; PMCID: PMC7135076.
2. Zhang JJ, Dong X, Liu GH, Gao YD. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19. PMID: 35044620; PMCID: PMC8767775.
3. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, He Y, Sun B, Wei M, Yang G, Wang X, Zhang L, Zhou X, Xing M, Wang PG. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility. Clin Infect Dis. 2021 Jul 15;73(2):328-331. doi: 10.1093/cid/ciaa1150. PMID: 32750119;
4. Garg I, Srivastava S, Dogra V, Bargotya M, Bhattar S, Gupta U, Jain S, Hussain J, Hembrom AA, Ghosh N, Kumar V, Kumar B, Varshney R, Ganju L. Potential association of COVID-19 and ABO blood group: An Indian study. Microb Pathog. 2021 Sep; 158:105008. doi: 10.1016/j.micpath.2021.105008. Epub 2021 Jun 1. PMID: 34087389; PMCID: PMC8168328.
5. Kwaghe VG, Habib ZG, Bawa A, Adebayo FO, Akor AA, Thairu Y, Ekele BA. Blood Group Distribution among COVID-19 Patients in a Nigerian Treatment Centre. West Afr J Med. 2021 May 29;38(5):494-497. PMID: 34051723.
6. Pendu JL, Breiman A, Rocher J, Dion M, Ruvoën-Clouet N. ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data. Viruses. 2021 Jan 22;13(2):160. doi: 10.3390/v13020160. PMID: 33499228; PMCID: PMC7911989.
7. Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L, Land K, Townsend M, Jecko T, Rahimi-Levene N, Patidar G, Josephson CD, Arora S, Vermeulen M, Vrielink H, Montemayor C, Oreh A, Hindawi S, van den Berg K, Serrano K, So-Osman C, Wood E, Devine DV, Spitalnik SL; ISBT COVID-19 Working Group. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group. Vox Sang. 2021 Sep;116 (8): 849-861. doi: 10.1111/vox.13076. Epub 2021 Feb 12. PMID: 33578447; PMCID: PMC8014128.
8. Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, Cooper J, Thiara S, Foster D, Chen LYC, Lee AYY, Conway EM, Wellington CL, Sekhon MS. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv. 2020 Oct 27;4(20):4981-4989. doi: 10.1182/bloodadvances.2020002623. PMID: 33057633; PMCID: PMC7594392.
9. Zietz M, Zucker J, Tatonetti NP. Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun. 2020 Nov 13;11(1):5761. doi: 10.1038/s41467-020-19623-x. PMID: 33188185; PMCID: PMC7666188.
10. Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020 Apr 30;130(4):304-309. doi: 10. 20452/ pamw.15272. Epub 2020 Mar 31. PMID: 32231171.
11. Gasmi A, Peana M, Pivina L, Srinath S, Gasmi Benahmed A, Semenova Y, Menzel A, Dadar M, Bjørklund G. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021 Mar;224:108651. doi: 10.1016/j.clim.2020.108651. Epub 2020 Dec 14. PMID: 33333255; PMCID: PMC7833539
12. Kulcsar KA, Coleman CM, Beck SE, Frieman MB. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019 Oct 17;4(20):e131774. doi: 10.1172/jci.insight.131774. PMID: 31550243; PMCID: PMC6 82 4443.